malondialdehyde has been researched along with fluticasone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, S; Besirli, K; Cetinkaya, A; Ozaras, R; Tahan, V; Talay, F; Turkmen, S; Uzun, H | 1 |
| Gur'eva, SA; Lapik, SV; Medvedeva, IV; Savina, IA | 1 |
1 trial(s) available for malondialdehyde and fluticasone
| Article | Year |
|---|---|
[Clinical and biochemical aspects of flixotide administration in patients with moderate bronchial asthma].
Topics: Adrenergic beta-Agonists; Adult; Albuterol; alpha-Tocopherol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Catalase; Drug Therapy, Combination; Female; Fluticasone; Glutathione Reductase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Phospholipids; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Schiff Bases; Superoxide Dismutase | 2002 |
1 other study(ies) available for malondialdehyde and fluticasone
| Article | Year |
|---|---|
Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Female; Fluticasone; Forced Expiratory Volume; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Salmeterol Xinafoate | 2000 |